Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATAZANAVIR Cause Pulmonary embolism? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Pulmonary embolism have been filed in association with ATAZANAVIR (Atazanavir Sulfate). This represents 0.4% of all adverse event reports for ATAZANAVIR.

20
Reports of Pulmonary embolism with ATAZANAVIR
0.4%
of all ATAZANAVIR reports
1
Deaths
7
Hospitalizations

How Dangerous Is Pulmonary embolism From ATAZANAVIR?

Of the 20 reports, 1 (5.0%) resulted in death, 7 (35.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATAZANAVIR. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does ATAZANAVIR Cause?

Foetal exposure during pregnancy (903) Drug interaction (730) Maternal exposure during pregnancy (653) Depression (590) Exposure during pregnancy (295) Abortion spontaneous (275) Premature baby (256) Virologic failure (201) Loss of personal independence in daily activities (167) Premature delivery (159)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which ATAZANAVIR Alternatives Have Lower Pulmonary embolism Risk?

ATAZANAVIR vs ATAZANAVIR\COBICISTAT ATAZANAVIR vs ATAZANAVIR\RITONAVIR ATAZANAVIR vs ATENOLOL ATAZANAVIR vs ATENOLOL\CHLORTHALIDONE ATAZANAVIR vs ATEZOLIZUMAB

Related Pages

ATAZANAVIR Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism ATAZANAVIR Demographics